Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort studyFrancesco Passamonti, Celestino Ferrandina, Nicola Stefano Fracchiolla et al.|The Lancet Haematology|2020Cited by 553
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological MalignanciesGiuseppe Messina, Benedetto Bruno, Luisa Giaccone et al.|Biology of Blood and Marrow Transplantation|2012Cited by 30
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiencyAlbino Carrizzo, Carmine Vecchione, Concetta Iside et al.|Cellular and Molecular Life Sciences|2022Cited by 29
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI)Massimo Breccia, Filíppo Gherlinzoni, Francesca Palandri et al.|Cancer|2025Cited by 10
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood MalignanciesGabriele Carullo, Giuseppe Campiani, Sara Rossi et al.|ACS Pharmacology & Translational Science|2024Cited by 7